Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Neoplasms 2Stress, Psychological 1Head and Neck Neoplasms 1Alzheimer Disease 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Amyloid × Clear all
NCT05126823 2026-05-05

Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients

Universidad de Córdoba

Phase NA Active not recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting
125 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02939612 2025-03-20

Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

Oslo University Hospital

Phase NA Active not recruiting
200 enrolled

Alzheimer Disease, Neoplasms, Stress, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡